Rigel Pharmaceuticals (RIGL) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $47.25, +0.92% vs the prior close of $46.82.
- Volume 167.80K shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
RIGL rises 0.9% to $47.25. Closed at $47.25, +0.92% vs the prior close of $46.82. Day range $47.01–$48.52, opened at $47.01.
RIGL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — RIGL rises 0.9% to $47.25
- Closed at $47.25, +0.92% vs the prior close of $46.82. Day range $47.01–$48.52, opened at $47.01.
- Volume was 167.80K shares, 0.6x its 50-day average of 275.41K.
- Price is +2.2% vs its 50-day average ($46.21) and +28.6% vs its 200-day average ($36.75).
- 52-week range $24.95–$52.24; today's close sits at 82% of that range, 9.6% below the 52-week high.
Oct 14, 2026 — RIGL dips 0.7% to $46.82, 3 down days in a row
- Closed at $46.82, -0.68% vs the prior close of $47.14. Day range $46.37–$47.99, opened at $46.82.
- Volume was 160.10K shares, 0.6x its 50-day average of 278.88K — lighter than usual.
- Price is +1.6% vs its 50-day average ($46.08) and +27.5% vs its 200-day average ($36.73).
- 52-week range $24.95–$52.24; today's close sits at 80% of that range, 10.4% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — RIGL slides 3.4% to $47.14
- Closed at $47.14, -3.42% vs the prior close of $48.81. Day range $47.04–$48.87, opened at $48.70.
- Volume was 134.00K shares, 0.5x its 50-day average of 279.95K — lighter than usual.
- Price is +2.7% vs its 50-day average ($45.91) and +28.4% vs its 200-day average ($36.72).
- 52-week range $24.95–$52.24; today's close sits at 81% of that range, 9.8% below the 52-week high.
Oct 12, 2026 — RIGL dips 0.6% to $48.81
- Closed at $48.81, -0.55% vs the prior close of $49.08. Day range $48.54–$49.89, opened at $49.22.
- Volume was 162.50K shares, 0.6x its 50-day average of 280.20K — lighter than usual.
- Price is +6.8% vs its 50-day average ($45.72) and +33.0% vs its 200-day average ($36.70).
- 52-week range $24.95–$52.24; today's close sits at 87% of that range, 6.6% below the 52-week high.
Oct 9, 2026 — RIGL rises 0.7% to $49.08, 3 up days in a row
- Closed at $49.08, +0.74% vs the prior close of $48.72. Day range $48.60–$50.49, opened at $48.60.
- Volume was 279.40K shares, 1.0x its 50-day average of 278.93K.
- Price is +7.9% vs its 50-day average ($45.48) and +33.8% vs its 200-day average ($36.68).
- 52-week range $24.95–$52.24; today's close sits at 88% of that range, 6.0% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — RIGL rises 1.5% to $48.72
- Closed at $48.72, +1.52% vs the prior close of $47.99. Day range $46.56–$48.89, opened at $47.33.
- Volume was 216.80K shares, 0.8x its 50-day average of 279.06K.
- Price is +7.6% vs its 50-day average ($45.26) and +32.9% vs its 200-day average ($36.65).
- 52-week range $24.95–$52.24; today's close sits at 87% of that range, 6.7% below the 52-week high.
Oct 7, 2026 — RIGL jumps 4.1% to $47.99
- Closed at $47.99, +4.08% vs the prior close of $46.11. Day range $45.22–$48.15, opened at $45.64.
- Volume was 232.60K shares, 0.8x its 50-day average of 277.26K.
- Price is +6.5% vs its 50-day average ($45.07) and +31.1% vs its 200-day average ($36.62).
- 52-week range $24.95–$52.24; today's close sits at 84% of that range, 8.1% below the 52-week high.
Oct 6, 2026 — RIGL slides 3.5% to $46.11
- Closed at $46.11, -3.52% vs the prior close of $47.79. Day range $45.93–$48.18, opened at $48.18.
- Volume was 202.60K shares, 0.7x its 50-day average of 277.80K.
- Price is +2.7% vs its 50-day average ($44.88) and +26.0% vs its 200-day average ($36.59).
- 52-week range $24.95–$52.24; today's close sits at 78% of that range, 11.7% below the 52-week high.
Oct 5, 2026 — RIGL rises 1.4% to $47.79
- Closed at $47.79, +1.36% vs the prior close of $47.15. Day range $46.93–$48.83, opened at $47.02.
- Volume was 391.60K shares, 1.4x its 50-day average of 279.67K.
- Price is +6.9% vs its 50-day average ($44.70) and +30.7% vs its 200-day average ($36.57).
- 52-week range $24.95–$52.24; today's close sits at 84% of that range, 8.5% below the 52-week high.
Oct 2, 2026 — RIGL rises 0.4% to $47.15
- Closed at $47.15, +0.38% vs the prior close of $46.97. Day range $46.45–$48.00, opened at $47.66.
- Volume was 185.70K shares, 0.7x its 50-day average of 283.62K.
- Price is +6.0% vs its 50-day average ($44.48) and +29.0% vs its 200-day average ($36.54).
- 52-week range $24.95–$52.24; today's close sits at 81% of that range, 9.7% below the 52-week high.
RIGL latest news & SEC filings
Every SEC filing by or about RIGL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 4, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 4, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $78.70M (prior year $101.69M) (-22.6% vs Jun 30, 2025)
- Net income: $17.29M (prior year $59.61M) (-71.0% vs Jun 30, 2025)
- Diluted EPS: $0.88 (prior year $3.28) (-73.2% vs Jun 30, 2025)
Jul 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jun 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ali-Jackson Kamil sold 2,500 shares at $35.00 (≈$87.50K) on Jun 22, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade RIGL
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Mar 3, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.67% (largest 4.1%).
- Liquidity: about 241.54K shares (≈$11.41M) trade per day on average.
- 52-week position: $47.25 vs a range of $24.95–$52.24 (82% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 3 sales; latest: Kamil Ali-Jackson sold 2,500 shares on Jun 22, 2026.
- Latest filings: 8-K Aug 4, 2026; 10-Q Aug 4, 2026; 8-K Jul 1, 2026.
- Share count: 18.68M shares outstanding (Jul 30, 2026), +4.1% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
RIGL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 47.01 | 48.52 | 47.01 | 47.25 | 167.80K |
| Oct 14, 2026 | 46.82 | 47.99 | 46.37 | 46.82 | 160.10K |
| Oct 13, 2026 | 48.70 | 48.87 | 47.04 | 47.14 | 134.00K |
| Oct 12, 2026 | 49.22 | 49.89 | 48.54 | 48.81 | 162.50K |
| Oct 9, 2026 | 48.60 | 50.49 | 48.60 | 49.08 | 279.40K |
| Oct 8, 2026 | 47.33 | 48.89 | 46.56 | 48.72 | 216.80K |
| Oct 7, 2026 | 45.64 | 48.15 | 45.22 | 47.99 | 232.60K |
| Oct 6, 2026 | 48.18 | 48.18 | 45.93 | 46.11 | 202.60K |
| Oct 5, 2026 | 47.02 | 48.83 | 46.93 | 47.79 | 391.60K |
| Oct 2, 2026 | 47.66 | 48.00 | 46.45 | 47.15 | 185.70K |
| Oct 1, 2026 | 48.05 | 48.87 | 46.81 | 46.97 | 235.00K |
| Sep 30, 2026 | 49.27 | 49.70 | 47.80 | 48.15 | 252.20K |
| Sep 29, 2026 | 49.38 | 49.70 | 48.61 | 48.89 | 182.20K |
| Sep 28, 2026 | 48.16 | 49.65 | 47.49 | 49.36 | 180.90K |
| Sep 25, 2026 | 48.23 | 48.53 | 47.20 | 48.18 | 204.90K |
| Sep 24, 2026 | 47.87 | 48.14 | 47.00 | 47.89 | 143.80K |
| Sep 23, 2026 | 48.62 | 48.69 | 46.91 | 48.13 | 151.40K |
| Sep 22, 2026 | 47.50 | 49.02 | 47.23 | 48.82 | 242.90K |
| Sep 21, 2026 | 47.13 | 47.51 | 46.49 | 47.09 | 164.80K |
| Sep 18, 2026 | 45.54 | 46.99 | 45.24 | 46.64 | 939.60K |
About Rigel Pharmaceuticals
Rigel Pharmaceuticals (RIGL) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SOUTH SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1034842.
RIGL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kamil Ali-Jackson | Director | Jun 24, 2026 |
| Mark W Frohlich | Director | May 19, 2026 |
| Anthony Gregg Lapointe | Director | May 19, 2026 |
| Michael Patrick Miller | Director | May 19, 2026 |
| Walter H Moos | Director | May 19, 2026 |
| Raul R Rodriguez | CEO, President | Sep 3, 2026 |
| Jane Wasman | Director | May 19, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Raymond J. Furey | EVP, GC, CCO & Corp Sec | Sep 3, 2026 |
| Alison L. Hannah | EVP, Chief Medical Officer | Jul 10, 2026 |
| Raul R Rodriguez | CEO, President | Sep 3, 2026 |
| Lisa Rojkjaer | EVP, Chief Medical Officer | Jun 22, 2026 |
| David A Santos | EVP, Chief Commercial Officer | Sep 3, 2026 |
| Dean L Schorno | EVP & Chief Financial Officer | Sep 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 22, 2026 | Kamil Ali-Jackson | Sale | 2,500 | $35.00 |
| May 26, 2026 | Kamil Ali-Jackson | Sale | 2,500 | $29.17 |
| Feb 20, 2026 | Walter H Moos | Sale | 4,000 | $36.36 |
RIGL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $294.28M | $367.02M | 19.48 | $75.66M |
| Dec 31, 2024 | $179.28M | $17.48M | 0.99 | $31.47M |
| Dec 31, 2023 | $116.88M | $-25.09M | -1.44 | $-5.74M |
| Dec 31, 2022 | $120.24M | $-58.57M | -3.44 | $-73.76M |
| Dec 31, 2021 | $149.24M | $-17.91M | -0.11 | $5.88M |
Latest balance sheet: total assets $521.07M, total liabilities $95.64M, cash $60.82M (as of Jun 30, 2026).
RIGL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $38.70 |
| May 5, 2026 | 8-K Item 2.02 (results) | $28.09 |
| Mar 3, 2026 | 8-K Item 2.02 (results) | $33.02 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $39.96 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $28.38 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $24.24 |
| May 6, 2025 | 8-K Item 2.02 (results) | $18.26 |
| Mar 4, 2025 | 8-K Item 2.02 (results) | $22.08 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $17.11 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $15.44 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on RIGL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.